EyePoint (EYPT) Cash from Investing Activities (QoQ) (2010 - 2026)
EyePoint (EYPT) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | EyePoint | 1.07 Mn | -221.48 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179.09% |
| Dec 31, 2025 | -234.81% |
| Sep 30, 2025 | 14.58% |
| Jun 30, 2025 | 22.29% |
| Mar 31, 2025 | 141.19% |
| Dec 31, 2024 | -692.50% |
| Sep 30, 2024 | 110.10% |
| Jun 30, 2024 | -870.91% |
| Mar 31, 2024 | 144.13% |
| Dec 31, 2023 | -2,641.16% |
| Sep 30, 2023 | -112.77% |
| Jun 30, 2023 | -58.03% |
| Mar 31, 2023 | -2.52% |
| Dec 31, 2022 | 424.82% |
| Sep 30, 2022 | 52,366.67% |
| Jun 30, 2022 | 99.98% |
| Mar 31, 2022 | -71.22% |
| Dec 31, 2021 | -25,064.12% |
| Sep 30, 2021 | -424.00% |
| Dec 31, 2020 | -50.00% |